|
|
Volumn 33, Issue 28, 2015, Pages 3193-3198
|
|
Immune-related adverse events, need for systemic immunosuppression, and effects on survival and time to treatment failure in patients with melanoma treated with ipilimumab at memorial sloan kettering cancer center
a
a
a
a
a,c
a,c
a,c
a,c
a,c
a
a
a,b,c
a,c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
CORTICOSTEROID;
INFLIXIMAB;
IPILIMUMAB;
MYCOPHENOLIC ACID;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
ANTINEOPLASTIC AGENT;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR;
ADULT;
AGED;
ARTHRITIS;
ARTICLE;
CANCER CENTER;
CANCER CONTROL;
CANCER PATIENT;
CANCER SURVIVAL;
COLITIS;
CORTICOSTEROID THERAPY;
DERMATITIS;
DIARRHEA;
DRUG MEGADOSE;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
ENDOCRINE DISEASE;
FEMALE;
HEARING IMPAIRMENT;
HEPATITIS;
HUMAN;
HYPOPHYSITIS;
IMMUNOPATHOLOGY;
IMMUNOSUPPRESSIVE TREATMENT;
INFUSION RELATED REACTION;
INTESTINE PERFORATION;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
MALE;
METASTATIC MELANOMA;
NEUROTOXICITY;
OVERALL SURVIVAL;
PNEUMONIA;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SEIZURE;
SINGLE DRUG DOSE;
SURVIVAL RATE;
SYSTEMIC THERAPY;
TIME TO TREATMENT;
TREATMENT RESPONSE;
UVEITIS;
ANTAGONISTS AND INHIBITORS;
DISEASE FREE SURVIVAL;
DRUG SUBSTITUTION;
IMMUNOLOGY;
KAPLAN MEIER METHOD;
MEDICAL RECORD;
MELANOMA;
MIDDLE AGED;
MORTALITY;
NEW YORK;
PATHOLOGY;
RISK FACTOR;
SECONDARY;
SKIN NEOPLASMS;
TIME FACTOR;
TREATMENT FAILURE;
VERY ELDERLY;
YOUNG ADULT;
ADRENAL CORTEX HORMONES;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
DISEASE-FREE SURVIVAL;
DRUG SUBSTITUTION;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KAPLAN-MEIER ESTIMATE;
MALE;
MEDICAL RECORDS;
MELANOMA;
MIDDLE AGED;
NEW YORK CITY;
RETROSPECTIVE STUDIES;
RISK FACTORS;
SKIN NEOPLASMS;
TIME FACTORS;
TREATMENT FAILURE;
TUMOR NECROSIS FACTOR-ALPHA;
YOUNG ADULT;
|
|
EID: 84944261579
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2015.60.8448 Document Type: Article |
|
Times cited : (872)
|
|
References (9)
|
